BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
News | 05. 21. 2013
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
